453 related articles for article (PubMed ID: 1971504)
1. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
2. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
Lane HC; Falloon J; Walker RE; Deyton L; Kovacs JA; Masur H; Banks S; Kirk LE; Baseler MW; Salzman NP
Ann Intern Med; 1989 Jul; 111(1):41-50. PubMed ID: 2735626
[TBL] [Abstract][Full Text] [Related]
7. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
[TBL] [Abstract][Full Text] [Related]
10. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
Podzamczer D; Bolao F; Clotet B; García P; Casanova A; Pagerols X; Gudiol F
J Intern Med; 1993 Mar; 233(3):247-53. PubMed ID: 8095516
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.
Mauss S; Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):157-62. PubMed ID: 7552479
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with ZDV and interferon-alpha-2a promotes tumor regression.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363699
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
[TBL] [Abstract][Full Text] [Related]
14. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
de Wit R; Schattenkerk JK; Boucher CA; Bakker PJ; Veenhof KH; Danner SA
Lancet; 1988 Nov; 2(8622):1214-7. PubMed ID: 2903953
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J
J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
Am J Clin Oncol; 1991; 14 Suppl 1():S40-4. PubMed ID: 2048563
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma.
Fischl MA
Am J Med; 1991 Apr; 90(4A):2S-7S. PubMed ID: 2018047
[TBL] [Abstract][Full Text] [Related]
19. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
Lane HC; Kovacs JA; Feinberg J; Herpin B; Davey V; Walker R; Deyton L; Metcalf JA; Baseler M; Salzman N
Lancet; 1988 Nov; 2(8622):1218-22. PubMed ID: 2903954
[TBL] [Abstract][Full Text] [Related]
20. Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.
Krown SE; Aeppli D; Balfour HH
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):245-54. PubMed ID: 10077172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]